Lung cancer

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0

View Activity

Immuno-Oncology Forum III: Focus on NSCLC

Immuno-Oncology Forum III: Focus on NSCLC

The rapid evolution and integration of immune checkpoint inhibitors into t…

Expiration Date: 2/28/2019

Max Credits: 0

View Activity

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

GameOn! Test Your Confidence Regarding Immune Checkpoint Inhibition for Cancer Management

The integration of immune checkpoint inhibitors into treatment strategies …

Expiration Date: 2/23/2018

Max Credits: 0

View Activity

Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

Globally, lung cancer is the leading cause of cancer-related deaths. Non-s…

Expiration Date: 8/15/2016

Max Credits: 0

View Activity

Immunotherapy Updates 2015: FOCUS on NSCLC

Immunotherapy Updates 2015: FOCUS on NSCLC

Globally, lung cancer is the leading cause of cancer-related deaths. Non-s…

Expiration Date: 7/28/2016

Max Credits: 0

View Activity

Advances in Immunotherapy in Non-Small Cell Lung Cancer

Advances in Immunotherapy in Non-Small Cell Lung Cancer

This article will inform clinicians involved in the treatment of NSCLC of …

Expiration Date: 9/25/2012

Max Credits: 0

View Activity

Advances in Immunotherapy in Non-Small Cell Lung Cancer

Advances in Immunotherapy in Non-Small Cell Lung Cancer

Immunotherapy is emerging as a promising approach to the treatment of non-…

Expiration Date: 8/18/2012

Max Credits: 0

View Activity